Advertisement
Advertisement
AORT
Artivion, Inc.
35.25
USDSponsored
+1.80
+5.38%
Apr 07, 16:00 UTC -4
Closed
After-Market
35.25
0.00
0.00%
AORT Earnings Reports
Positive Surprise Ratio
AORT beat 27 of 40 last estimates.
68%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$118.09M
/$0.04
Implied change from Q4 25 (Revenue/ EPS)
+1.81%
/-20.00%
Implied change from Q1 25 (Revenue/ EPS)
+19.31%
/-500.00%
Artivion, Inc. earnings per share and revenue
On Feb 12, 2026, AORT reported earnings of 0.05 USD per share (EPS) for Q4 25, missing the estimate of 0.08 USD, resulting in a -39.98% surprise. Revenue reached 115.99 million, compared to an expected 118.75 million, with a -2.32% difference. The market reacted with a -9.96% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of 0.04 USD, with revenue projected to reach 118.09 million USD, implying an decrease of -20.00% EPS, and increase of 1.81% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
Microbot Medical, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+34.64%
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.22
Surprise
-69.10%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Atossa Therapeutics, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.16
Actual
-$3.08
Surprise
-165.45%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
FAQ
What were Artivion, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Artivion, Inc. reported EPS of $0.05, missing estimates by -39.98%, and revenue of $115.99M, -2.32% below expectations.
How did the market react to Artivion, Inc.'s Q4 2025 earnings?
The stock price moved down -9.96%, changed from $40.65 before the earnings release to $36.60 the day after.
When is Artivion, Inc. expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Artivion, Inc.'s next earnings report?
Based on 8
analysts, Artivion, Inc. is expected to report EPS of $0.04 and revenue of $118.09M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement